FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2918072253> ?p ?o ?g. }

• W2918072253 abstract "In the past decade, direct-acting oral anticoagulants (DOAC) have been introduced to medical practice for several indications, with a wide range of dosing regimens. As both over- and under-dosing might lead to life-threatening events, development of methods promoting safe and effective utilization of these agents is imperative. The Hadassah Clinical Pharmacy team initiated a hospital-wide program, for monitoring and promoting safe and effective prescription of DOAC during hospitalization. This study describes the types of drug related problems addressed and the program’s performance in terms of consultation rates and physician acceptance. Electronic medical records throughout the hospital were screened for DOAC orders. All DOAC orders were assessed by a clinical pharmacist for potentially-inappropriate prescribing. When potentially-inappropriate prescribing or a drug-related problem was identified, the clinical pharmacist provided consultation on management options. In specific cases, additional guidance was provided by coagulation and pharmacology specialists. Data on patient characteristics, clinical pharmacist consultations, and physician response was retrospectively retrieved for the first six months of 2017. Characteristics of patients with and without consultations were compared, consultations were categorized by the recommended management of the drug related problem, and physician acceptance rates were evaluated by category. During the evaluated period, 585 patients with DOAC orders were identified. Patients were evenly distributed by gender, and age averaged 78 years. Most patients received apixaban (75%) followed by rivaroxaban (14%) and dabigatran (11%), and most (63%) received “reduced dose” regimens. Clinical pharmacists provided 258 consultations for 210 patients, regarding anticoagulation management, such that more than one in three patients on DOAC had potentially inappropriate prescribing or drug related problems. Consultations included alerts regarding potentially inappropriate DOAC doses and recommendations to increase (29%) or decrease (5%) the dose, potentially inappropriate concomitant antiplatelet agents (20%), need for DOAC level monitoring (23%), and alerts regarding other drug related problems (23%). More than 70% of recommendations were accepted by the attending physician. Due to the complexity of DOAC management, potentially-inappropriate prescribing and drug related problems are common. Multidisciplinary collaborative projects including review and consultation by clinical pharmacists are an effective method of improving management of patients on DOAC. Retrospectively registered at clinicaltrials.gov, NCT03527615 ." @default.
• W2918072253 created "2019-03-02" @default.
• W2918072253 creator A5007305947 @default.
• W2918072253 creator A5007909706 @default.
• W2918072253 creator A5015937599 @default.
• W2918072253 creator A5044907057 @default.
• W2918072253 creator A5046168057 @default.
• W2918072253 creator A5065579365 @default.
• W2918072253 creator A5087778366 @default.
• W2918072253 date "2019-02-01" @default.
• W2918072253 modified "2023-10-09" @default.
• W2918072253 title "Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program" @default.
• W2918072253 cites W1969879564 @default.
• W2918072253 cites W197947778 @default.
• W2918072253 cites W1993053792 @default.
• W2918072253 cites W2010861397 @default.
• W2918072253 cites W2020214475 @default.
• W2918072253 cites W2044459782 @default.
• W2918072253 cites W2110922423 @default.
• W2918072253 cites W2114191043 @default.
• W2918072253 cites W2121927413 @default.
• W2918072253 cites W2129896132 @default.
• W2918072253 cites W2252823734 @default.
• W2918072253 cites W2298015487 @default.
• W2918072253 cites W2334748385 @default.
• W2918072253 cites W2466439889 @default.
• W2918072253 cites W2468230121 @default.
• W2918072253 cites W2469963671 @default.
• W2918072253 cites W2509795914 @default.
• W2918072253 cites W2511291692 @default.
• W2918072253 cites W2551817902 @default.
• W2918072253 cites W2564543296 @default.
• W2918072253 cites W2587045166 @default.
• W2918072253 cites W2595260576 @default.
• W2918072253 cites W2606507895 @default.
• W2918072253 cites W2618243683 @default.
• W2918072253 cites W2622276831 @default.
• W2918072253 cites W2727978886 @default.
• W2918072253 cites W2736956220 @default.
• W2918072253 cites W2737746416 @default.
• W2918072253 cites W2753755263 @default.
• W2918072253 cites W2766383072 @default.
• W2918072253 cites W2769275060 @default.
• W2918072253 cites W2769760280 @default.
• W2918072253 cites W2770462959 @default.
• W2918072253 cites W2790375504 @default.
• W2918072253 cites W2800664739 @default.
• W2918072253 cites W2886027203 @default.
• W2918072253 cites W3023357416 @default.
• W2918072253 cites W576717100 @default.
• W2918072253 doi "https://doi.org/10.1186/s13584-019-0285-9" @default.
• W2918072253 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6357500" @default.
• W2918072253 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30709417" @default.
• W2918072253 hasPublicationYear "2019" @default.
• W2918072253 type Work @default.
• W2918072253 sameAs 2918072253 @default.
• W2918072253 citedByCount "22" @default.
• W2918072253 countsByYear W29180722532019 @default.
• W2918072253 countsByYear W29180722532020 @default.
• W2918072253 countsByYear W29180722532021 @default.
• W2918072253 countsByYear W29180722532022 @default.
• W2918072253 countsByYear W29180722532023 @default.
• W2918072253 crossrefType "journal-article" @default.
• W2918072253 hasAuthorship W2918072253A5007305947 @default.
• W2918072253 hasAuthorship W2918072253A5007909706 @default.
• W2918072253 hasAuthorship W2918072253A5015937599 @default.
• W2918072253 hasAuthorship W2918072253A5044907057 @default.
• W2918072253 hasAuthorship W2918072253A5046168057 @default.
• W2918072253 hasAuthorship W2918072253A5065579365 @default.
• W2918072253 hasAuthorship W2918072253A5087778366 @default.
• W2918072253 hasBestOaLocation W29180722531 @default.
• W2918072253 hasConcept C100406419 @default.
• W2918072253 hasConcept C10446079 @default.
• W2918072253 hasConcept C104863432 @default.
• W2918072253 hasConcept C126322002 @default.
• W2918072253 hasConcept C137992405 @default.
• W2918072253 hasConcept C138816342 @default.
• W2918072253 hasConcept C159110408 @default.
• W2918072253 hasConcept C177713679 @default.
• W2918072253 hasConcept C194828623 @default.
• W2918072253 hasConcept C195910791 @default.
• W2918072253 hasConcept C2426938 @default.
• W2918072253 hasConcept C2776301958 @default.
• W2918072253 hasConcept C2777288759 @default.
• W2918072253 hasConcept C2778661090 @default.
• W2918072253 hasConcept C2778810321 @default.
• W2918072253 hasConcept C2779161974 @default.
• W2918072253 hasConcept C2779457091 @default.
• W2918072253 hasConcept C2780638905 @default.
• W2918072253 hasConcept C2780877353 @default.
• W2918072253 hasConcept C2910723583 @default.
• W2918072253 hasConcept C512399662 @default.
• W2918072253 hasConcept C71924100 @default.
• W2918072253 hasConceptScore W2918072253C100406419 @default.
• W2918072253 hasConceptScore W2918072253C10446079 @default.
• W2918072253 hasConceptScore W2918072253C104863432 @default.
• W2918072253 hasConceptScore W2918072253C126322002 @default.
• W2918072253 hasConceptScore W2918072253C137992405 @default.
• W2918072253 hasConceptScore W2918072253C138816342 @default.
• W2918072253 hasConceptScore W2918072253C159110408 @default.

• next